Serum MCP-1 was a promising non-invasive tool for the diagnosis of NASH in the Egyptian population, confirming the role of MCP-1 in the pathogenesis of NASH [47]. This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatohepatitis.